Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delta-8-THC vs Delta-9-THC on Simulated Driving Performance
NCT06218550Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Jul 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of delta-8-tetrahydrocannabinol (8 arms), sponsored by Johns Hopkins University. Primary endpoint: Standard Deviation of Lateral Position. Started Jul 2024; status: completed.
02
Drugs
delta-8-tetrahydrocannabinol
Beyond the preview
Go deeper on NCT06218550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06218550.